Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Molecular mechanism involved in arteriosclerosis--the roles of nitric oxide and Rho/Rho-kinase].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2001
Same author

Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo.

Arteriosclerosis, thrombosis, and vascular biology·2001
Same author

Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.

American journal of physiology. Heart and circulatory physiology·2001
Same author

Glutamate release via NO production evoked by NMDA in the NTS enhances hypotension and bradycardia in vivo.

American journal of physiology. Regulatory, integrative and comparative physiology·2001
Same author

Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001
Same author

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Blood·2001

Related Experiment Video

Updated: Jul 11, 2026

Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice
09:56

Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice

Published on: February 14, 2021

Baroreflex sensitivity in patients with Takayasu's aortitis.

A Takeshita, S Tanaka, Y Orita

    Circulation
    |May 1, 1977
    PubMed
    Summary

    Patients with Takayasu's aortitis have significantly reduced baroreflex sensitivity, impacting blood pressure regulation. This finding challenges the common theory that fainting in this condition stems from overactive baroreceptors.

    More Related Videos

    Isolated Lung Perfusion System in the Rabbit Model
    10:18

    Isolated Lung Perfusion System in the Rabbit Model

    Published on: July 15, 2021

    Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
    06:04

    Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

    Published on: September 27, 2024

    Related Experiment Videos

    Last Updated: Jul 11, 2026

    Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice
    09:56

    Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice

    Published on: February 14, 2021

    Isolated Lung Perfusion System in the Rabbit Model
    10:18

    Isolated Lung Perfusion System in the Rabbit Model

    Published on: July 15, 2021

    Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
    06:04

    Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

    Published on: September 27, 2024

    Area of Science:

    • Cardiovascular Medicine
    • Immunology
    • Neurology

    Background:

    • Takayasu's aortitis is a rare inflammatory arterial disease of unknown cause.
    • Fainting (syncope) is a frequent symptom, often attributed to baroreflex hypersensitivity.
    • Baroreflex sensitivity plays a crucial role in maintaining cardiovascular homeostasis.

    Purpose of the Study:

    • To investigate baroreflex sensitivity in patients with Takayasu's aortitis.
    • To compare baroreflex sensitivity between patients and healthy controls.
    • To explore the relationship between baroreflex sensitivity and fainting in Takayasu's aortitis.

    Main Methods:

    • Assessed baroreflex sensitivity using the phenylephrine method in 11 Takayasu's aortitis patients and 8 controls.
    • Measured the R-R interval changes in response to induced systolic arterial pressure increases.
    • Calculated the slope of the regression line relating blood pressure rise to R-R interval prolongation.

    Main Results:

    • Takayasu's aortitis patients exhibited significantly reduced baroreflex sensitivity (4.0 msec/mm Hg) compared to controls (10.7 msec/mm Hg).
    • Reduced sensitivity was observed even in patients experiencing fainting.
    • Underlying hypertension or cardiac disease may contribute to diminished baroreflex function.

    Conclusions:

    • Baroreflex sensitivity is markedly impaired in Takayasu's aortitis.
    • The findings suggest arterial stiffening or associated comorbidities, not baroreceptor hyperreactivity, underlie fainting in this disease.
    • This research reframes the understanding of syncope mechanisms in Takayasu's aortitis.